UT Health Science Center's Liza Makowski, PhD Helps Lead Global Conversation on GLP-1 Drugs and Cancer Risk
November 06, 2025
November 06, 2025
MEMPHIS, Tennessee, Nov. 6 -- The University of Tennessee Health Science Center issued the following news:
* * *
UT Health Science Center's Liza Makowski, PhD, Helps Lead Global Conversation on GLP-1 Drugs and Cancer Risk
By Chris Green
Blockbuster drugs like Ozempic, Wegovy, and Zepbound have transformed obesity care for millions of Americans, making them some of the most talked-about medical breakthroughs of the decade. Yet several quest . . .
* * *
UT Health Science Center's Liza Makowski, PhD, Helps Lead Global Conversation on GLP-1 Drugs and Cancer Risk
By Chris Green
Blockbuster drugs like Ozempic, Wegovy, and Zepbound have transformed obesity care for millions of Americans, making them some of the most talked-about medical breakthroughs of the decade. Yet several quest . . .
